Florence Riant1, Reda Mourtada, Pascale Saugier-Veber, Elisabeth Tournier-Lasserve. 1. Laboratoire de Génétique, Groupe Hospitalier Lariboisière-Fernand Widal, Groupement Hospitalier-Universitaire Nord, Assistance Publique-Hôpitaux de Paris, 2 Rue Ambroise Paré, 75010 Paris, France. florence.riant@lrb.aphp.fr
Abstract
BACKGROUND: Episodic ataxia (EA) is an ion channel disorder that manifests as paroxysmal attacks of imbalance and incoordination. Episodic ataxia type 2 (EA2) is characterized by prolonged episodes of ataxia with interictal nystagmus and is caused by mutations in CACNA1A. All mutations identified thus far (to our knowledge) are nonsense or missense point mutations. OBJECTIVE: To describe a family with EA2 having a novel mutation deleting several exons of CACNA1A. DESIGN: Clinical and molecular study of a family manifesting EA2 attacks. SETTING: Academic research. PATIENTS: DNA was extracted from blood samples of 3 family members. MAIN OUTCOME MEASURES: Microsatellite genotyping of CACNA1A, quantitative multiplex polymerase chain reaction of short fluorescent fragments (QMPSF), and sequencing were performed. RESULTS: Genotyping of CACNA1A showed nonmendelian inheritance of a CAG repeat located at the 3' end of the gene in a mother and daughter, suggesting a deletion event, which was subsequently confirmed by QMPSF analysis and sequencing. This 39.5-kilobase deletion removes the last 16 coding exons of the gene. CONCLUSION: Deletion of several exons of CACNA1A may cause EA2 and should be assessed in patients having EA2 without a CACNA1A point mutation.
BACKGROUND:Episodic ataxia (EA) is an ion channel disorder that manifests as paroxysmal attacks of imbalance and incoordination. Episodic ataxia type 2 (EA2) is characterized by prolonged episodes of ataxia with interictal nystagmus and is caused by mutations in CACNA1A. All mutations identified thus far (to our knowledge) are nonsense or missense point mutations. OBJECTIVE: To describe a family with EA2 having a novel mutation deleting several exons of CACNA1A. DESIGN: Clinical and molecular study of a family manifesting EA2 attacks. SETTING: Academic research. PATIENTS: DNA was extracted from blood samples of 3 family members. MAIN OUTCOME MEASURES: Microsatellite genotyping of CACNA1A, quantitative multiplex polymerase chain reaction of short fluorescent fragments (QMPSF), and sequencing were performed. RESULTS: Genotyping of CACNA1A showed nonmendelian inheritance of a CAG repeat located at the 3' end of the gene in a mother and daughter, suggesting a deletion event, which was subsequently confirmed by QMPSF analysis and sequencing. This 39.5-kilobase deletion removes the last 16 coding exons of the gene. CONCLUSION: Deletion of several exons of CACNA1A may cause EA2 and should be assessed in patients having EA2 without a CACNA1A point mutation.
Authors: Xiaofei Du; Cenfu Wei; Daniel Parviz Hejazi Pastor; Eshaan R Rao; Yan Li; Giorgio Grasselli; Jack Godfrey; Ann C Palmenberg; Jorge Andrade; Christian Hansel; Christopher M Gomez Journal: Neuron Date: 2019-03-25 Impact factor: 17.173
Authors: Sanjeev Rajakulendran; Tracey D Graves; Robyn W Labrum; Dimitrios Kotzadimitriou; Louise Eunson; Mary B Davis; Rosalyn Davies; Nicholas W Wood; Dimitri M Kullmann; Michael G Hanna; Stephanie Schorge Journal: J Physiol Date: 2010-02-15 Impact factor: 5.182
Authors: Stephanie Schorge; Joyce van de Leemput; Andrew Singleton; Henry Houlden; John Hardy Journal: Trends Neurosci Date: 2010-03-11 Impact factor: 13.837